Aldeyra Therapeutics, Inc.
NASDAQ:ALDX
5.34 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||||
| Net Income
| -37.543 | -62.025 | -57.776 | -37.554 | -60.827 | -38.893 | -22.341 | -18.699 | -12.09 | -5.187 | 13.06 | -23.075 | -2.378 |
| Depreciation & Amortization
| 0.263 | 0.259 | 0.264 | 0.056 | 0.096 | 0.071 | 0.038 | 0.036 | 0.019 | 0.001 | 0 | 0.004 | 0.002 |
| Deferred Income Tax
| -1.204 | 0 | 0 | -0.479 | -1.31 | -0.238 | 0.129 | 0.266 | 0 | -2.328 | 0 | 0.135 | 0 |
| Stock Based Compensation
| 5.753 | 8.289 | 7.108 | 7.084 | 8.083 | 4.145 | 2.715 | 2.76 | 2.187 | 2.037 | 1.702 | 0.084 | 0.05 |
| Change In Working Capital
| 0.861 | -3.444 | 7.439 | -8.83 | 2.741 | 4.998 | 0.215 | 0.463 | 0.537 | 0.55 | 0.26 | 0.092 | -0.066 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| 1.204 | -0.886 | 0.638 | -0.427 | -2.846 | 2.05 | 0.726 | -0.576 | 0.51 | -0.001 | 0.269 | 0.047 | -0.166 |
| Other Working Capital
| -0.343 | -2.558 | 6.801 | -8.403 | 5.587 | 2.949 | -0.51 | 1.039 | 0.027 | 0.55 | -0.01 | 0.045 | 0.1 |
| Other Non Cash Items
| 1.544 | 0.284 | 0.409 | 2.229 | 6.233 | 0.059 | 0.02 | 0.027 | 0.036 | 0.151 | -16.728 | 21.982 | 0 |
| Operating Cash Flow
| -30.326 | -56.637 | -42.556 | -37.493 | -44.984 | -29.857 | -19.223 | -15.148 | -9.312 | -4.776 | -1.707 | -0.778 | -2.393 |
| Investing Activities: | |||||||||||||
| Investments In Property Plant And Equipment
| -0 | -0.016 | -0.008 | 0 | -0.01 | -0.263 | -0.025 | -0.012 | -0.086 | -0.014 | 0 | 0 | 0 |
| Acquisitions Net
| 0 | 0.016 | 0 | 0 | 0.609 | 262,966 | 24,759 | 0.012 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | -92.938 | 0 | -5.776 | -57.768 | -59.732 | -35.095 | -16.048 | -12.95 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 30 | 63 | 0 | 34.8 | 75.645 | 36.659 | 24.922 | 15.835 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0.03 | -0.016 | -7,806 | 0.029 | 0.018 | -262,966 | -24,759 | -0.012 | -12.95 | -0.014 | 0 | 0 | 0 |
| Investing Cash Flow
| 30 | -29.955 | -0.008 | 29.024 | 18.477 | -23.336 | -10.198 | -0.225 | -13.036 | -0.014 | 0 | 0 | 0 |
| Financing Activities: | |||||||||||||
| Debt Repayment
| -1.043 | 0 | 0 | 0 | -14.327 | -1.396 | 0 | 0 | 0 | -1.396 | -0.104 | 0 | 0 |
| Common Stock Issued
| 0.305 | 1.123 | 189.812 | 41.902 | 7.892 | 81.923 | 37.595 | 12.739 | 28.506 | 10.055 | 0.007 | 0 | 0 |
| Common Stock Repurchased
| -0.533 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -0.533 | 0.097 | 4.685 | 41.902 | 30.011 | -1.396 | -0.166 | 12.739 | -0.036 | 1.396 | 3.842 | 1.751 | 0 |
| Financing Cash Flow
| -1.27 | 1.22 | 194.496 | 41.902 | 23.576 | 80.527 | 37.429 | 12.739 | 28.47 | 10.055 | 3.745 | 1.751 | 0 |
| Other Information: | |||||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -1.596 | -85.372 | 151.933 | 33.432 | -2.932 | 27.334 | 8.008 | -2.634 | 6.122 | 5.265 | 2.039 | 0.973 | -2.393 |
| Cash At End Of Period
| 142.823 | 144.419 | 229.791 | 77.858 | 44.426 | 47.357 | 20.023 | 12.015 | 14.649 | 8.527 | 3.262 | 1.224 | 0.251 |